losing muscle mass on semaglutide Tirzepatide vs. Semaglutide: Which GLP-1 Better Preserves During Weight Loss? Bodyfat loss with some muscle

Description

Semaglutide was approved in 2022 for use alongside lifestyle changes in pediatric patients aged 12 or older with an initial BMI equal to or greater than the 95th percentile for their age and sex

It is a medication used to treat type 2 diabetes mellitus, a condition in which the body is unable to properly use insulin, leading to high blood sugar levels

Healthcare providers should carefully evaluate the potential risks and benefits of Semaglutide therapy, obtain informed consent from patients, and document discussions regarding off-label use, alternative treatments, and potential risks

Early detection of possible infections

That is a clinically useful result for a short-term, low-cost agent but it is roughly half to a third of what semaglutide achieves over a longer horizon, and phentermine's effect is studied over a much shorter window